BRNS
Barinthus Biotherapeutics
BRNS
BRNS
13 hedge funds and large institutions have $23.2M invested in Barinthus Biotherapeutics in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
+1
Holders Change %
+8.33%
% of All Funds
0.22%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
2
Increased
1
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
HH
HSG Holding
Na,
Hong Kong
|
+$6.32M |
2 |
Tudor Investment Corp
Stamford,
Connecticut
|
+$1.19M |
3 |
Morgan Stanley
New York
|
+$19.9K |
Top Sellers
1 |
IIM
Ipswich Investment Management
Beverly,
Massachusetts
|
-$55.2K |
2 |
Millennium Management
New York
|
-$32.3K |
3 |
UBS Group
Zurich,
Switzerland
|
-$6.47K |